CS logo
small CS logo
BCCA-Centre for the North

Prince George, British Columbia, Canada
Cancer treatment center in Prince George, British Columbia
1215 Lethbridge St, Prince George, BC V2M 7E9

About BCCA-Centre for the North


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at BCCA-Centre for the North


During the past decade, BCCA-Centre for the North conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "BCCA-Centre for the North" #1 collaborator was "Beacon Hospital, Ireland" with 1 trials as a collaborator, "British Columbia Cancer Agency" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "Insight Genetics" with 1 trials as a collaborator and "London Regional Cancer Program, Canada" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

Clinical Trials Conditions at BCCA-Centre for the North


According to Clinical.Site data, the most researched conditions in "BCCA-Centre for the North" are "Metastatic Tumors" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasm Female" (1 trials), "Cosmetic Outcome" (1 trials) and "Metastatic Cancer" (1 trials). Many other conditions were trialed in "BCCA-Centre for the North" in a lesser frequency.

Clinical Trials Intervention Types at BCCA-Centre for the North


Most popular intervention types in "BCCA-Centre for the North" are "Radiation" (7 trials), "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "20 Gy in 5 fractions" (1 trials), "ALK qPCR assay" (1 trials), "Abiraterone acetate" (1 trials), "Cisplatin" (1 trials) and "Conventional SBRT: 24 Gy in 2 fractions" (1 trials). Other intervention names were less common.

Clinical Trials Genders at BCCA-Centre for the North


The vast majority of trials in "BCCA-Centre for the North" are 7 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at BCCA-Centre for the North


Currently, there are NaN active trials in "BCCA-Centre for the North". 1 are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in BCCA-Centre for the North, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in BCCA-Centre for the North, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".